Key facts
- Head Diagnostics’s last known valuation is $26.6M (Dec 2025).
- It has raised $13.6M; the latest was Later Stage VC ($5.2M) in Dec 2025.
- Notable investors include Enterprise Ireland, NDRC, PharmStars, Ambit Health Ventures, Aran Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Head Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Head Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Head Diagnostics
Developer of digital neurotechnology designed to advance brain health diagnostics and monitoring. The company offers iTremor One, a device measuring oscillatory movement traits (OMT) as a neurophysiological brain biomarker, and HDx Cognition, a cognitive assessment tool, enabling healthcare providers to access objective, scalable insights into neurological function across clinical settings.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2018
- Employees
- 18
- Website
- headdiagnostics.com/
- Ownership
- Privately Held (backing)
Head Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Head Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Head Diagnostics in its N-PORT filings yet. We sweep new filings monthly.